ClinicalTrials.gg
CompletedNCT03476785LVHUpdated Oct 14, 2019

Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease

An interventional study of High intensity exercise and Yoga in Lv Hypertrophy, Heart Failure, Diastolic and Stiffness, Vascular, sponsored by University of Texas Southwestern Medical Center. Completed at 1 site in United States. Open to participants aged 40 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-14.

Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Jun 2015, registered Mar 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
40 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 38 studies in Hypertrophy, Left Ventricular with a site in United States — 7 open to participants now, 8 under way, none of them phase 3. Hypertrophy, Left Ventricular · United States.

Enrollment
16th of 26
56 · median 94
Started
2015
with 2 others
No phase
10 of 38
1 open now
Registered
26th of 38
by date
Lead sponsor
2 of 38
University of Texas Southwestern Medical Center

Among the 38 studies in Hypertrophy, Left Ventricular with a site in United States, this one is the 16th largest by enrollment of the 26 interventional ones that give a count, is one of 3 that started in 2015, is one of 10 with no phase, and was the 26th registered.

Hypertrophy, Left Ventricular

162 studies on the registry are indexed under Hypertrophy, Left Ventricular; 28 are open to participants now.

This study's enrollment of 56 is below the median of 100 across 97 interventional studies indexed under Hypertrophy, Left Ventricular.

Browse Hypertrophy, Left Ventricular studies →

Open to participants now

7 of the 38 studies in Hypertrophy, Left Ventricular with a site in United States are open now, in 4 countries. Each count lists the studies.

All 7 open studies →

Who these studies take

Of the 20 Hypertrophy, Left Ventricular studies recruiting now, 13 (65%) set no upper age limit and 2 (10%) stop at 75 or younger; 4 take children under 18; 7 take healthy volunteers.

This study: 40 Years to 64 Years · all sexes · healthy volunteers too.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Hypertrophy, Left Ventricular with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether vigorous exercise training 4-5 days/week for one year in sedentary middle aged (ages 40-64) individuals at high risk for future development of heart failure will improve cardiac and vascular compliance to a degree equivalent to life-long exercisers and the sedentary young. To date, no effective therapy for heart failure with preserved ejection fraction (HFpEF) has been found; therefore prevention is critical and discovering novel treatment strategies is essential. Exercise training if implemented in high risk patients may improve diastolic function and cardiac-vascular interactions, preventing further progression to overt heart failure.

Read the detailed description

The global objective of this project is to test novel strategies to prevent diastolic dysfunction associated with HFpEF; these include: a) identifying high risk individuals by using population derived imaging and blood biomarkers; and b) implementing novel exercise training strategies in these middle age individuals, when cardiac plasticity still exists, to forestall the development of diastolic abnormalities that progress to HFpEF.

Prior research has demonstrated that: a) healthy but sedentary aging leads to atrophy and stiffening of the heart with reduced myocardial and chamber compliance; b) in contrast, highly competitive senior athletes had cardiac compliance that was indistinguishable from healthy young individuals suggesting that lifelong exercise training prevented this stiffening; c) even prolonged and intense exercise training started after age 65 failed to reverse age-related cardiac and vascular stiffening; d) cardiac stiffening begins in middle age (40-64) and can be substantially prevented by training 4-5 days/wk. The primary objective of this project is therefore to identify high risk sedentary individuals age 40-64, and initiate an exercise program carefully designed to maximize effects on cardiovascular compliance and function. Findings from this aim would have enormous public health significance and establish a novel, practical exercise training strategy designed to reverse cardiovascular stiffening.

Hypothesis:

Exercise training, when implemented 4-5 times/week over a prolonged period of time in sedentary high risk middle aged men and women, age 40-64 will improve cardiac and vascular compliance to a degree equivalent to life-long exercisers (and sedentary young);

Specific Aim:

To test the hypothesis, two groups of previously sedentary subjects, ages 40-64 at particularly high risk for HF will be studied for one year, with the following interventions: 1) subjects undergoing prolonged endurance/interval/strength exercise training; and 2) strength and flexibility /balance control. Subjects will be categorized as high risk and enrolled on the basis of elevated serum biomarkers and left ventricular hypertrophy (LVH) documented by cardiac MRI. Comprehensive invasive and non-invasive assessment of cardiovascular structure and systolic/diastolic function will be performed before and after 1 year of an exercise intervention involving high intensity aerobic intervals, lower intensity endurance training, and strength training, compared with strength and flexibility control.

03

Conditions studied

  • Lv Hypertrophy
  • Heart Failure, Diastolic
  • Stiffness, Vascular

Keywords

  • LVH
  • Ventricular Stiffness
  • Fitness
  • HFpEF
04

Who can participate

Ages eligible
40 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of left ventricular hypertrophy (by MRI, echocardiography or )
  • Normal (>50%)
  • Elevated cardiac biomarker (high sensitivity troponin, NT-BNP)

Exclusion criteria

Exclusion Criteria:

  • age \< 40 or >64
  • >35
  • history of heart failure, myocarditis, restrictive cardiomyopathy, severe , unstable coronary artery disease or recent (\<12 month) acute coronary syndrome, cerebrovascular disease as evidenced by prior or stroke and active/recent tobacco use (quit \< 5 years).
  • chronic orthopedic injury that precludes exercise testing
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    High Intensity Exercise

    Subjects randomized to receive high intensity aerobic exercise will undergo exercise training for 1 year. A training program will be developed individually for each subject with the goal of increasing duration and intensity consistent with exercise training principles. Workouts will vary with respect to mode (walk, cycle) and duration (30 - 60 minutes). Each subject will be assigned an exercise physiologist and a heart rate monitor so that each session can be tracked and recorded.

    Behavioral: High intensity exercise

  • Placebo comparator
    Yoga

    Subjects randomized to yoga will receive instructions on strength and flexibility exercises.

    Behavioral: Yoga

Interventions

  • BehavioralHigh intensity exercise

    Subjects will perform high intensity aerobic exercise in addition to moderate intensity sessions 4-5 times per week.

  • BehavioralYoga

    Subjects will perform strength and flexibility exercises.

06

What researchers measure

Primary outcomes

  1. Left ventricular stiffness

    Change in ventricular stiffness after 1 year of exercise training measured as the stiffness constant of the diastolic limb of the left ventricular pressure-volume curve

    Time frame: 1 year

Secondary outcomes

  1. Aerobic fitness

    Change in peak aerobic capacity (VO2) after 1 year of exercise training

    Time frame: 1 year

  2. Vascular stiffness

    Change in pulse wave velocity after 1 year of exercise training

    Time frame: 1 year

07

Study locations

1 site
  • The Institute for Exercise and Environmental Medicine
    Dallas, Texas 75231, United States
08

References and documents

Publications

  • Hieda M, Sarma S, Hearon CM Jr, MacNamara JP, Dias KA, Samels M, Palmer D, Livingston S, Morris M, Levine BD. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction. Circulation. 2021 Sep 21;144(12):934-946. doi: 10.1161/CIRCULATIONAHA.121.054117. Epub 2021 Sep 20. PubMed 34543068 ↗
  • Hieda M, Sarma S, Hearon CM Jr, Dias KA, Martinez J, Samels M, Everding B, Palmer D, Livingston S, Morris M, Howden E, Levine BD. Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction. Circulation. 2020 Jan 14;141(2):115-123. doi: 10.1161/CIRCULATIONAHA.119.040332. Epub 2019 Dec 23. PubMed 31865771 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2015 to primary completion in Jul 2019, 49 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 1, 2018
First posted
Mar 26, 2018
StartActual
Jun 1, 2015
Primary completionActual
Jul 2, 2019
CompletionActual
Jul 2, 2019
Last update
Oct 14, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 14, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03476785
Responsible party
Sponsor
First posted
Mar 26, 2018
Start date
Jun 1, 2015
Primary completion
Jul 2, 2019
Completion
Jul 2, 2019
Last update
Oct 14, 2019

Study contacts

Benjamin D Levine, MD
principal investigator · University of Texas Southwestern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion